This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Apr;5(4):184-5.

doi: 10.1038/ncpuro1076. Epub 2008 Mar 11.

Is androgen suppression therapy associated with early onset of fatal myocardial infarction?

Martin G Sanda¹, Mohit Kasibhatla

Affiliations

PMID: 18334975
DOI: 10.1038/ncpuro1076

Comment

Is androgen suppression therapy associated with early onset of fatal myocardial infarction?

Martin G Sanda et al. Nat Clin Pract Urol. 2008 Apr.

. 2008 Apr;5(4):184-5.

doi: 10.1038/ncpuro1076. Epub 2008 Mar 11.

Authors

Martin G Sanda¹, Mohit Kasibhatla

Affiliation

¹ Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. msanda@bidmc.harvard.edu

PMID: 18334975
DOI: 10.1038/ncpuro1076

No abstract available

PubMed Disclaimer

Comment on

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
D'Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS, Joseph D, Tai KH, Malone S, Ludgate C, Steigler A, Kantoff PW. D'Amico AV, et al. J Clin Oncol. 2007 Jun 10;25(17):2420-5. doi: 10.1200/JCO.2006.09.3369. J Clin Oncol. 2007. PMID: 17557956

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.